Dalteparin-induced skin necrosis in a patient with metastatic lung adenocarcinoma.
Moore
Allan
A
Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. afmoore@partners.org
Lau
Evan
E
Yang
Clarissa
C
Mackool
Bonnie
B
Kuter
David J
DJ
D000230:Adenocarcinoma / Q000150:complications* / Q000556:secondary; D000925:Anticoagulants / Q000009:adverse effects*; D017985:Dalteparin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications / Q000556:secondary; D008175:Lung Neoplasms / Q000150:complications* / Q000473:pathology; D008875:Middle Aged; D009336:Necrosis; D011655:Pulmonary Embolism / Q000188:drug therapy; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology; D020246:Venous Thrombosis / Q000188:drug therapy
D000925:Anticoagulants; D017985:Dalteparin